Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
about
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV InfectionA Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All CancersNon-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraHepatitis B and A vaccination in HIV-infected adults: A reviewHepatitis B and human immunodeficiency virus co-infectionHIV infection, aging, and immune function: implications for cancer risk and preventionRelationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.Liver disease, HIV and aging.Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesisNon-AIDS-Defining Malignancies in the HIV-Infected PopulationChanging patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Pattern of cancer risk in persons with AIDS in Italy in the HAART era.Evolving epidemiology of HIV-associated malignancies.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients.The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.An immunization update for HIV-infected adults in the United States: review of the literatureCauses of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.Hepatocellular carcinoma in HIV-infected patients: check early, treat hardHIV infection, immunodeficiency, viral replication, and the risk of cancer.FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patientsAssociation between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional studyChallenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited SettingsEffect of Hepatitis B Virus Co-Infection on CD4 Cell Count and Liver Function of HIV Infected Patients.Cancers attributable to infections among adults with HIV in the United States.Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans.Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.Cancer prevention in HIV-infected populations.Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.The role of viral co-infection in HIV-associated non-AIDS-related cancersSubstance abuse, HIV-1 and hepatitisHepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunitiesCancer risk in HIV-infected persons: influence of CD4(+) count.Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.Multiple infections and cancer: implications in epidemiology.
P2860
Q26749811-7253CEEF-A161-44ED-BF2D-A614682F653BQ26777111-5DBB19BE-5086-4464-8025-86633D87DBA7Q26797897-00F21B65-18E5-460C-8671-642F845F073CQ26799782-C6581B9C-5795-41C2-8F0D-2894B785CCF2Q26822862-2B71D9C1-8B97-42CD-A251-B82D76B1E863Q27004165-A8E13B29-FC65-45FF-8907-5E9FE8855810Q33696149-D6458657-FFDD-4CF3-971C-CD87D4457420Q33810577-63D248C4-D92A-4F10-9A38-47214220D532Q33851416-DE41506D-768C-480C-AD89-39F90E651363Q33859370-E84699FA-26E3-469B-AB2B-DBAE9E307922Q34059657-5FDC0CBA-7CF3-4B63-8264-31167D5ABB7EQ34158436-08C20827-3D07-4586-A481-E40634132024Q34405008-5D66407F-24C0-4FF8-AEED-BFC70B9957CEQ34604639-B4849D9D-C464-405E-9FC3-1E8ACA68ACEEQ34679292-165E0B3B-2D12-4E2C-9E6A-0858F63F880FQ34765478-38DA7D5F-4048-4E1C-A57F-B2F22A902DA0Q34966832-1ECB64D7-6ACA-487B-96B1-30759A5B37A9Q35026139-221955DC-BBD3-4362-B6F6-110F218DF522Q35102095-F3318239-FE69-4232-87A3-E9C3542EE03FQ35127068-F5AF789A-64C3-466D-970E-2A46A257E86EQ35169664-83A4636B-4CC0-4227-B257-1258A84DD1E6Q35584805-B6384A62-6600-44B3-A688-F2621A87BF02Q35612742-8EC5C25C-5033-4C7A-8278-04D293F654D9Q35613547-6B13EC07-A4AA-4547-AA14-5258638367FCQ35803583-5289E956-DA05-4373-BB25-6004E9547A3BQ35866994-7B1C49B5-4FA8-4F18-8E99-642DB8D8570EQ35996793-D58FD911-8694-4859-B844-D3B007EEB43AQ36259445-B18308BD-42AA-40D8-93F6-25F970EE00A5Q36407167-6C50310B-4DAF-4D77-92C7-FDD6547E8524Q36550695-0B39CFAF-1EA4-4CC4-A7D2-170439D2A56EQ36680086-618E6D5F-8A85-4A49-ADC3-D5AD41E35956Q36699256-C97E75CC-2B49-4BD3-8672-6736513CE89FQ36960884-2ED889E1-569B-49CD-A9CD-D37465F197EDQ37003023-B3A13A8A-3530-416A-9C0B-06FC415C2588Q37167046-2C53666F-81FF-439B-B2DA-5E3AE7AD5E38Q37180845-C08EEF30-050E-483D-B5B6-CFCD399E7C81Q37515370-527F8365-FD4C-4126-9828-A75CBA445D3FQ37632401-B431F3CE-0AAF-4608-9E78-16FBA6FFEEDBQ37662407-BF58C19C-1C39-477D-9ED8-0734C4C74008Q38126931-08E6332C-E9C5-496F-B05A-30C259C4A654
P2860
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@ast
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@en
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@nl
type
label
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@ast
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@en
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@nl
prefLabel
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@ast
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@en
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@nl
P2093
P50
P1433
P1476
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
@en
P2093
Andri Rauch
Bruno Ledergerber
Christine Bouchardy
Fabio Levi
Gary M Clifford
Ingrid Steffen
Martin Rickenbach
Swiss HIV Cohort
P304
P356
10.1097/QAD.0B013E32831103AD
P407
P577
2008-10-01T00:00:00Z